NCT01244711View on ClinicalTrials.gov

Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines

PHASE4TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Major DepressionGeneralized Anxiety Disorder
Interventions
DRUG

quetiapine

Dosing will begin with Seroquel-XR 50 mg. at bedtime and will escalate weekly to Seroquel-XR 100mg., Seroquel-XR 200mg. and Seroquel-XR 300 mg depending on clinical response and side effects.

Trial Locations (1)

10065

Weill Cornell Medical College, New York

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Weill Medical College of Cornell University

OTHER